Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
681
Demographic information.
Published 2025“…These results highlight decreased sound tolerance as a significant issue at Canadian post-secondary institutions, calling for steps to be taken to mitigate its effects.…”
-
682
SHAP dependence plots with interaction coloring.
Published 2025“…</p><p>Conclusion</p><p>This first NHANES-based study demonstrates a significant negative correlation between eGDR and frailty, confirming DM’s partial mediating role. …”
-
683
Screening process diagram.
Published 2025“…</p><p>Conclusion</p><p>This first NHANES-based study demonstrates a significant negative correlation between eGDR and frailty, confirming DM’s partial mediating role. …”
-
684
SHAP waterfall plot.
Published 2025“…</p><p>Conclusion</p><p>This first NHANES-based study demonstrates a significant negative correlation between eGDR and frailty, confirming DM’s partial mediating role. …”
-
685
SHAP decision plot.
Published 2025“…</p><p>Conclusion</p><p>This first NHANES-based study demonstrates a significant negative correlation between eGDR and frailty, confirming DM’s partial mediating role. …”
-
686
LASSO regression visualization plot.
Published 2025“…</p><p>Conclusion</p><p>This first NHANES-based study demonstrates a significant negative correlation between eGDR and frailty, confirming DM’s partial mediating role. …”
-
687
Overall analysis of randomized controlled trials.
Published 2025“…Stratification by a longer treatment duration of more than four months revealed that atorvastatin achieved the most significant reduction in IL-6 and TNF-α. …”
-
688
SHAP dependence plots.
Published 2025“…</p><p>Conclusion</p><p>This first NHANES-based study demonstrates a significant negative correlation between eGDR and frailty, confirming DM’s partial mediating role. …”
-
689
Tertile stratified subgroup analysis.
Published 2025“…</p><p>Conclusion</p><p>This first NHANES-based study demonstrates a significant negative correlation between eGDR and frailty, confirming DM’s partial mediating role. …”
-
690
Newcastle-Ottawa scale.
Published 2025“…Stratification by a longer treatment duration of more than four months revealed that atorvastatin achieved the most significant reduction in IL-6 and TNF-α. …”
-
691
Characteristics of JIA patients.
Published 2025“…Following biologic therapy, growth delay decreased to 8% and impaired growth to 36.8%. Patients with systemic JIA showed lower changes in growth parameters compared to others, and no significant differences were observed between different biologic drugs. …”
-
692
List of excluded articles.
Published 2025“…Following biologic therapy, growth delay decreased to 8% and impaired growth to 36.8%. Patients with systemic JIA showed lower changes in growth parameters compared to others, and no significant differences were observed between different biologic drugs. …”
-
693
Image1_The immunological and prognostic significance of the diabetes mellitus-related gene WFS1 in endometrial cancer.tif
Published 2024“…</p>Methods<p>Using the CTD, GeneCards, and GSEA databases, we identified WFS1 as a diabetes-related gene and then conducted an extensive investigation focusing on WFS1 in the context of EC. …”
-
694
Table2_The immunological and prognostic significance of the diabetes mellitus-related gene WFS1 in endometrial cancer.xlsx
Published 2024“…</p>Methods<p>Using the CTD, GeneCards, and GSEA databases, we identified WFS1 as a diabetes-related gene and then conducted an extensive investigation focusing on WFS1 in the context of EC. …”
-
695
Table3_The immunological and prognostic significance of the diabetes mellitus-related gene WFS1 in endometrial cancer.docx
Published 2024“…</p>Methods<p>Using the CTD, GeneCards, and GSEA databases, we identified WFS1 as a diabetes-related gene and then conducted an extensive investigation focusing on WFS1 in the context of EC. …”
-
696
Table1_The immunological and prognostic significance of the diabetes mellitus-related gene WFS1 in endometrial cancer.xlsx
Published 2024“…</p>Methods<p>Using the CTD, GeneCards, and GSEA databases, we identified WFS1 as a diabetes-related gene and then conducted an extensive investigation focusing on WFS1 in the context of EC. …”
-
697
Mortality dataset used in analysis.
Published 2025“…<div><p>Background</p><p>Uganda reported a significant reduction in the mortality rate of children under 5 years of age, from 146/1,000 live births in 2000–42/1,000 live births in 2021. …”
-
698
Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay
Published 2025“…By developing a delivery vector that specifically targets circulating malignant cells (CMCs) in patient blood samples, we established an ex vivo platform to study the dynamic interplay between patient-derived cancer cells and immune cells. …”
-
699
Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay
Published 2025“…By developing a delivery vector that specifically targets circulating malignant cells (CMCs) in patient blood samples, we established an ex vivo platform to study the dynamic interplay between patient-derived cancer cells and immune cells. …”
-
700
Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay
Published 2025“…By developing a delivery vector that specifically targets circulating malignant cells (CMCs) in patient blood samples, we established an ex vivo platform to study the dynamic interplay between patient-derived cancer cells and immune cells. …”